# SPYRAL DYSTAL Renal Denervation Global Clinical Study

> **NCT04311086** · NA · COMPLETED · sponsor: **Medtronic Vascular** · enrollment: 128 (actual)

## Conditions studied

- Hypertension
- Vascular Diseases
- Cardiovascular Diseases

## Interventions

- **DEVICE:** Renal Denervation (Symplicity Spyral™)

## Key facts

- **NCT ID:** NCT04311086
- **Lead sponsor:** Medtronic Vascular
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-12
- **Primary completion:** 2022-12-22
- **Final completion:** 2022-12-22
- **Target enrollment:** 128 (ACTUAL)
- **Last updated:** 2024-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04311086

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04311086, "SPYRAL DYSTAL Renal Denervation Global Clinical Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04311086. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*